Growing Number Of Opioid Addiction Cases: Strategic Insights Driving Opioid Use Disorder (OUD) Market Momentum in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Opioid Use Disorder (OUD) Market Size By 2025?
The market size for opioid use disorder (OUD) has experienced a quick expansion in the past few years. The growth is projected to rise from $3.96 billion in 2024 to $4.39 billion in 2025, boasting a compound annual growth rate (CAGR) of 10.9%. This historical period of growth is credited to factors such as inflated prescription rates, pain management protocols, drug marketing tactics, and the stigmatization of addiction.

How Big Is the Opioid Use Disorder (OUD) Market Size Expected to Grow by 2029?
Anticipated swift expansion is on the horizon for the opioid use disorder (OUD) market with projections placing its worth at $6.94 billion by 2029. This translates to a compound annual growth rate (CAGR) of 12.1%. This growth during the forecast period is largely attributed to regulatory intercessions, an emphasis on alternative pain management strategies, broadened treatment access, and public health schemes. Trends expected to influence this growth include technological advancements in treatment, personalized treatment methods, integrated care models, community-rooted support programs, as well as early prevention and intervention initiatives.

View the full report here:
https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

Which Key Market Drivers Powering Opioid Use Disorder (OUD) Market Expansion and Growth?
The opioid use disorder (OUD) market is likely to expand due to the escalating cases of opioid addiction. This addiction is identified as a medical condition that constitutes compulsive, chronic opioid use with detrimental impacts on health. Opioids generate a feeling of euphoria and relieve pain; however, constant usage can cultivate tolerance, necessitating higher doses for the same effect and potentially leading to opioid use disorder. For example, the Centers for Disease Control and Prevention, a US-based public health agency, reported in March 2024 that overdosage of synthetic opioid drugs surged by 4.1%, climbing from 21.8 to 22.7 between 2021 and 2022. As a result, the rising number of opioid addiction instances fuels the expansion of the opioid use disorder (OUD) market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Opioid Use Disorder (OUD) Market?
A key trend gaining traction within the opioid use disorder (OUD) market is product innovation. Major companies in the OUD market are using innovation to maintain their market presence, introducing new products to keep ahead of competition. For example, in May 2023, Brixadi (buprenorphine) extended-release injection was approved by the U.S. Food and Drug Administration, a federal agency in the US, as a remedy for moderate to severe OUD. The company offers this product in two forms: a weekly injection for patients already on the medication or starting treatment with a single dose of a transmucosal buprenorphine product, and a monthly variant for patients who are already on this treatment.

What Are the Emerging Segments in the Opioid Use Disorder (OUD) Market?
The opioid use disorder (OUD) market covered in this report is segmented -

1) By Drug Type: Buprenorphine, Naltrexone, Methadone
2) By Route of Administration: Oral, Parenteral
3) By Age Group: 19 To 40, 41 To 60, 61 And Over
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies

Subsegments:
1) By Buprenorphine: Suboxone, Buprenorphine Tablets, Buprenorphine Film
2) By Naltrexone: Naltrexone Tablets, Vivitrol
3) By Methadone: Methadone Tablets, Methadone Oral Solution

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12586&type=smp

Who Are the Global Leaders in the Opioid Use Disorder (OUD) Market?
Major companies operating in the opioid use disorder (OUD) market include Pfizer Inc., Novartis AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Chiesi Pharmaceuticals S.p.A., Hikma Pharmaceuticals Plc., Mallinckrodt Pharmaceuticals, Indivior Plc., Purdue Pharma L.P, Alkermes Inc., Collegium Pharmaceutical Inc., Vanda Pharmaceuticals Inc., Camurus AB, Tris Pharma Inc., Mylan NV., Orexo US Inc., Zogenix Inc., Rhodes Pharmaceuticals L.P., Omeros Corporation, Braeburn Pharmaceuticals Inc., Adapt Pharma Inc., Titan Pharmaceuticals Inc., BioDelivery Sciences International Inc., AcelRx Pharmaceuticals Inc., KemPharm Inc.

Which are the Top Profitable Regional Markets for the Opioid Use Disorder (OUD) Industry?
North America was the largest region in the opioid use disorder (OUD) market in 2024. The regions covered in the opioid use disorder (OUD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12586

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.